The design of active vehicle suspensions with integral constraints to control the response of a vehicle traversing a road is considered. The problem is initially formulated in the linear quadratic regulator (LQR) framework with full-state feedback. Alternate formulations based on optimal output feedback (OOFB) and the minimum norm criterion (MNC) approach in the absence of complete state information are then presented. A general expression for the required optimal value of the control force based on easily measurable feedback quantities is developed. To reduce the effect of the body jerk, the high rate of change of actuator control force is penalized by adding a roll-off prefilter to the control. Results based on LQR, OOFB, and MNC are compared, and it is shown that the OOFB and MNC give performances as effective as the full-state feedback without the need to measure the tire deflection. The effectiveness of the roll-off prefilter in reducing the body jerk is demonstrated in an example problem.
An optimal control design method based on the use of the correlation between the front and rear wheel inputs (wheelbase preview) is introduced and then applied to the optimum design of a slow-active suspension system. The suspension consists of a limited bandwidth actuator in series with a passive spring, the combination being in parallel with a passive damper. A three-dimensional seven degrees of freedom car riding model subjected to four correlated random road inputs is considered. The performance potential of the limited bandwidth system with wheelbase preview in comparison with the nonpreview (uncorrelated inputs) case is investigated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.